Safety, Resistance, and Efficacy Results From a Phase IIIb Study of Conventional- And Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients

Infectious Diseases and Therapy - United States
doi 10.1007/s40121-019-00271-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Efficacy and Safety of Oseltamivir in Treatment and Prevention of Influenza Virus Infection in Patients With Hemodialysis

Nihon Toseki Igakkai Zasshi
2010English

Efficacy, Safety and Population Pharmacokinetics of Sapropterin in PKU Patients <4 Years: Results From the SPARK Open-Label, Multicentre, Randomized Phase IIIb Trial

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2017English

Safety and Efficacy of Pasireotide in Dumping Syndrome-Results From a Phase 2, Multicentre Study

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

Clinical Therapeutics
Pharmacology
2016English

Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study With Vancomycin-Aztreonam

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Erratum to : Efficacy and Safety of the Selective Oral Neuraminidase Inhibitor Oseltamivir for Prophylaxis Against Influenza

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
2001English

Efficacy and Safety of Velmanase Alfa in the Treatment of Patients With Alpha-Mannosidosis: Results From the Core and Extension Phase Analysis of a Phase III Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial

Journal of Inherited Metabolic Disease
Genetics
2018English

Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results From a Randomised Phase 2 Study

British Journal of Dermatology
DermatologyMedicine
2019English

Efficacy and Safety of AR101 in Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy